Triamcinolone hexacetonide - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for triamcinolone hexacetonide and what is the scope of freedom to operate?
Triamcinolone hexacetonide
is the generic ingredient in one branded drug marketed by Sandoz and is included in one NDA. Additional information is available in the individual branded drug profile pages.There are five drug master file entries for triamcinolone hexacetonide.
Summary for triamcinolone hexacetonide
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Drug Master File Entries: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 33 |
Clinical Trials: | 20 |
Patent Applications: | 5,791 |
Formulation / Manufacturing: | see details |
DailyMed Link: | triamcinolone hexacetonide at DailyMed |
Recent Clinical Trials for triamcinolone hexacetonide
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Centre hospitalier de l'Université de Montréal (CHUM) | N/A |
Oslo University Hospital | Phase 4 |
Diakonhjemmet Hospital | Phase 4 |
US Patents and Regulatory Information for triamcinolone hexacetonide
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sandoz | ARISTOSPAN | triamcinolone hexacetonide | INJECTABLE;INJECTION | 016466-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sandoz | ARISTOSPAN | triamcinolone hexacetonide | INJECTABLE;INJECTION | 016466-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |